Literature DB >> 29579315

Co-expression of μ and δ opioid receptors by mouse colonic nociceptors.

Raquel Guerrero-Alba1, Eduardo Emmanuel Valdez-Morales1, Nestor Nivardo Jiménez-Vargas1, Romke Bron2, Daniel Poole2,3, David Reed1, Joel Castro4,5, Melissa Campaniello5, Patrick A Hughes5, Stuart M Brierley4,5, Nigel Bunnett2,6,7, Alan E Lomax1, Stephen Vanner1.   

Abstract

BACKGROUND AND
PURPOSE: To better understand opioid signalling in visceral nociceptors, we examined the expression and selective activation of μ and δ opioid receptors by dorsal root ganglia (DRG) neurons innervating the mouse colon. EXPERIMENTAL APPROACH: DRG neurons projecting to the colon were identified by retrograde tracing. δ receptor-GFP reporter mice, in situ hybridization, single-cell RT-PCR and μ receptor-specific antibodies were used to characterize expression of μ and δ receptors. Voltage-gated Ca2+ currents and neuronal excitability were recorded in small diameter nociceptive neurons (capacitance <30 pF) by patch clamp and ex vivo single-unit afferent recordings were obtained from the colon. KEY
RESULTS: In situ hybridization of oprm1 expression in Fast Blue-labelled DRG neurons was observed in 61% of neurons. μ and δ receptors were expressed by 36-46% of colon DRG neurons, and co-expressed by ~25% of neurons. μ and δ receptor agonists inhibited Ca2+ currents in DRG, effects blocked by opioid antagonists. One or both agonists inhibited action potential firing by colonic afferent endings. Incubation of neurons with supernatants from inflamed colon segments inhibited Ca2+ currents and neuronal excitability. Antagonists of μ, but not δ receptors, inhibited the effects of these supernatant on Ca2+ currents, whereas both antagonists inhibited their actions on neuronal excitability. CONCLUSIONS AND IMPLICATIONS: A significant number of small diameter colonic nociceptors co-express μ and δ receptors and are inhibited by agonists and endogenous opioids in inflamed tissues. Thus, opioids that act at μ or δ receptors, or their heterodimers may be effective in treating visceral pain.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29579315      PMCID: PMC6003632          DOI: 10.1111/bph.14222

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

1.  CD4+ T-cell modulation of visceral nociception in mice.

Authors:  Monica Verma-Gandhu; Premysl Bercik; Yasuaki Motomura; Elena F Verdu; Waliul I Khan; Patricia A Blennerhassett; Lu Wang; Rami T El-Sharkawy; Stephen M Collins
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

2.  Increased κ-opioid receptor expression and function during chronic visceral hypersensitivity.

Authors:  Patrick A Hughes; Joel Castro; Andrea M Harrington; Nicole Isaacs; Melissa Moretta; Gareth A Hicks; David M Urso; Stuart M Brierley
Journal:  Gut       Date:  2013-11-27       Impact factor: 23.059

3.  Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Authors:  D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

4.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.

Authors:  Stephen Ph Alexander; Arthur Christopoulos; Anthony P Davenport; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

5.  Co-expression of μ and δ opioid receptors by mouse colonic nociceptors.

Authors:  Raquel Guerrero-Alba; Eduardo Emmanuel Valdez-Morales; Nestor Nivardo Jiménez-Vargas; Romke Bron; Daniel Poole; David Reed; Joel Castro; Melissa Campaniello; Patrick A Hughes; Stuart M Brierley; Nigel Bunnett; Alan E Lomax; Stephen Vanner
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

6.  Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome.

Authors:  Douglas A Drossman; Carolyn B Morris; Hollie Edwards; Christina Ed Wrennall; Stephan R Weinland; Ademola O Aderoju; Renuka R Kulkarni-Kelapure; Yuming J Hu; Christine Dalton; Megan H Bouma; Joseph Zimmerman; Ceciel Rooker; Jane Leserman; Shrikant I Bangdiwala
Journal:  Am J Gastroenterol       Date:  2012-06-19       Impact factor: 10.864

7.  UMB-3, a novel rabbit monoclonal antibody, for assessing μ-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues.

Authors:  Amelie Lupp; Nadine Richter; Christian Doll; Falko Nagel; Stefan Schulz
Journal:  Regul Pept       Date:  2010-09-17

8.  Synthesis and biological evaluation of novel delta (δ) opioid receptor ligands with diazatricyclodecane skeletons.

Authors:  Giovanni Loriga; Paolo Lazzari; Stefania Ruiu; Giorgio Marchese; Ilaria Manca; Gian Luca Casu; Christian Dessì; Gérard Aimè Pinna; Battistina Asproni; Gabriele Murineddu
Journal:  Eur J Med Chem       Date:  2013-09-19       Impact factor: 6.514

9.  Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons.

Authors:  H C Moises; K I Rusin; R L Macdonald
Journal:  J Neurosci       Date:  1994-10       Impact factor: 6.167

10.  Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation.

Authors:  R R Ji; Q Zhang; P Y Law; H H Low; R Elde; T Hökfelt
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

View more
  9 in total

1.  Co-expression of μ and δ opioid receptors by mouse colonic nociceptors.

Authors:  Raquel Guerrero-Alba; Eduardo Emmanuel Valdez-Morales; Nestor Nivardo Jiménez-Vargas; Romke Bron; Daniel Poole; David Reed; Joel Castro; Melissa Campaniello; Patrick A Hughes; Stuart M Brierley; Nigel Bunnett; Alan E Lomax; Stephen Vanner
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

2.  Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.

Authors:  Nestor Nivardo Jiménez-Vargas; Yang Yu; Dane D Jensen; Diana Daeun Bok; Matthew Wisdom; Rocco Latorre; Cintya Lopez; Josue O Jaramillo-Polanco; Claudius Degro; Mabel Guzman-Rodriguez; Quentin Tsang; Zachary Snow; Brian L Schmidt; David E Reed; Alan Edward Lomax; Kara Gross Margolis; Christoph Stein; Nigel W Bunnett; Stephen J Vanner
Journal:  Gut       Date:  2021-03-30       Impact factor: 23.059

3.  Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice.

Authors:  Yang Yu; Quentin K Tsang; Josue Jaramillo-Polanco; Alan E Lomax; Stephen J Vanner; David E Reed
Journal:  J Neurosci       Date:  2022-07-05       Impact factor: 6.709

4.  Opioid-Induced Pronociceptive Signaling in the Gastrointestinal Tract Is Mediated by Delta-Opioid Receptor Signaling.

Authors:  Josue Jaramillo-Polanco; Cintya Lopez-Lopez; Yang Yu; Emma Neary; Alan Hegron; Meritxell Canals; Nigel W Bunnett; David E Reed; Alan E Lomax; Stephen J Vanner
Journal:  J Neurosci       Date:  2022-03-07       Impact factor: 6.709

5.  Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain.

Authors:  Nestor N Jimenez-Vargas; Jing Gong; Matthew J Wisdom; Dane D Jensen; Rocco Latorre; Alan Hegron; Shavonne Teng; Jesse J DiCello; Pradeep Rajasekhar; Nicholas A Veldhuis; Simona E Carbone; Yang Yu; Cintya Lopez-Lopez; Josue Jaramillo-Polanco; Meritxell Canals; David E Reed; Alan E Lomax; Brian L Schmidt; Kam W Leong; Stephen J Vanner; Michelle L Halls; Nigel W Bunnett; Daniel P Poole
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-16       Impact factor: 11.205

6.  Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents.

Authors:  Vinod Tiwari; Shao-Qiu He; Qian Huang; Lingli Liang; Fei Yang; Zhiyong Chen; Vineeta Tiwari; Wakako Fujita; Lakshmi A Devi; Xinzhong Dong; Yun Guan; Srinivasa N Raja
Journal:  Pain       Date:  2020-04       Impact factor: 7.926

7.  Delta opioid receptors on nociceptive sensory neurons mediate peripheral endogenous analgesia in colitis.

Authors:  Xavier Mas-Orea; Lilian Basso; Catherine Blanpied; Claire Gaveriaux-Ruff; Nicolas Cenac; Gilles Dietrich
Journal:  J Neuroinflammation       Date:  2022-01-06       Impact factor: 8.322

8.  Delta Opioid Receptor Agonists Ameliorate Colonic Inflammation by Modulating Immune Responses.

Authors:  Kazuki Nagata; Hiroshi Nagase; Ayumi Okuzumi; Chiharu Nishiyama
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 7.561

Review 9.  Knock-In Mouse Models to Investigate the Functions of Opioid Receptors in vivo.

Authors:  Jade Degrandmaison; Samuel Rochon-Haché; Jean-Luc Parent; Louis Gendron
Journal:  Front Cell Neurosci       Date:  2022-01-31       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.